CDK2 and neoplasm: Based on the EPIC algorithm, CCNA2 and CDK2 expression levels in SARC were negatively correlated with the infiltration level of CD4+ T cells (cor = −0.194, P = 2.62e−03; Figures S6, S5), implying that our dimers also could target CCNA2 and CDK2 to affect the tumor immunity in MG-63 cells.